Shimada, Japan

Naomi Kouno

This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naomi Kouno. Retrieved from https://idiyas.com/inventor/naomi-kouno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naomi Kouno: Innovator in Biopharmaceuticals

Introduction

Naomi Kouno is a prominent inventor based in Shimada, Japan. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of recombinant human proteins. Her work has implications for medical treatments and therapies.

Latest Patents

Naomi Kouno holds a patent for "DNA encoding human colony-stimulating factors." This invention relates to a biologically active recombinant human M-CSF obtained by expressing a human M-CSF gene coding for the amino acid sequence in its entirety or devoid of a portion thereof. The patent also includes a process for preparing the recombinant human M-CSF, an expression plasmid containing the human M-CSF gene, and a transformant harboring the expression plasmid.

Career Highlights

Kouno is currently associated with Otsuka Pharmaceutical Company, Limited, where she continues to advance her research and innovations in the pharmaceutical industry. Her work has been instrumental in enhancing the understanding and application of colony-stimulating factors in medical science.

Collaborations

Throughout her career, Naomi has collaborated with notable colleagues, including Tohru Hirato and Satoru Nakai. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Naomi Kouno's contributions to the field of biopharmaceuticals exemplify the impact of innovative research on medical science. Her patent on recombinant human M-CSF highlights her role as a leading inventor in this vital area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…